Enovis Q3 EPS beats estimates; raises FY profit outlook
ENOV•ENOV•ENOV•ENOV•Enovis reported Q3 sales of $558.73 million, up 2% year over year, and adjusted EPS of $0.88, beating analyst estimates. It raised its 2026 adjusted EBITDA and EPS outlook and authorized a new $200 million share repurchase program.
Enovis said Q3 sales rose 2% year over year to $558.73 million, slightly above the $557.01 million analyst estimate. Adjusted EPS was $0.88, beating the $0.77 estimate.
The company narrowed its 2026 revenue guidance to $2.32 billion-$2.35 billion from $2.31 billion-$2.37 billion. It raised its adjusted EBITDA outlook to $428 million-$438 million from $425 million-$435 million, and its adjusted EPS guidance to $3.58-$3.79 from $3.52-$3.73.
Enovis cited 6% sales growth in its Reconstructive business and momentum in new product introductions as supporting quarterly results. It also noted ongoing market volatility and cost inflation as challenges. The board approved a new $200 million share repurchase authorization.
